Advanced Medullary thyroid cancer

Drug	Drug Name	Drug Description
DB00851	Dacarbazine	An antineoplastic agent used to treat malignant melanoma and Hodgkin's disease.

Drug	Drug Name	Target	Type
DB00851	Dacarbazine	DNA polymerase alpha subunit B	target
DB00851	Dacarbazine	Cytochrome P450 1A1	enzyme
DB00851	Dacarbazine	Cytochrome P450 1A2	enzyme
DB00851	Dacarbazine	Cytochrome P450 2E1	enzyme
DB00851	Dacarbazine	6-phosphogluconate dehydrogenase, decarboxylating	target
DB00851	Dacarbazine	DNA	target

Drug	Drug Name	Phase	Status	Count